Factors influencing the features of postherpetic neuralgia and outcome when treated with tricyclics

European Journal of Pain

Volumn 7, Issue 1, 2003, Pages 1-7

  Bowsher, David ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Antivirals; Herpes zoster; Postherpetic neuralgia; Tricyclics

Indexed keywords

ACICLOVIR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLODYNIA; BURNING SENSATION; CHRONOLOGY; HERPES ZOSTER; HUMAN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

EID: 0037246146     PISSN: 10903801     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-3801(02)00060-5     Document Type: Article

References (33)

1. Alpers BS, Lewis PR. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?. J Fam Pract 2000;49:255-64.
2. Bhala BB, Ramamoorthy C, Bowsher D, Yelnoorker KN. Shingles and post-herpetic neuralgia. Clin J Pain 1988;4:169-74.
3. Bowsher D. Acute shingles and postherpetic neuralgia: effects of acyclovir and outcome of treatment with amitriptyline. Br J Gen Pract 1992;42:244-6.
4. Bowsher D. The effects of acyclovir therapy for herpes zoster on treatment outcome in postherpetic neuralgia: a randomised study. Eur J Pain 1994;15:9-12.
5. Bowsher D. Postherpetic neuralgia and its treatment: a retrospective survey of 191 patients. J Pain Symptom Manage 1996;12:290-9.
6. Bowsher D. The effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomised double-blind placebo-controlled trial. J Pain Symptom Manage 1997;13:327-31.
7. Bowsher D. The lifetime occurrence of herpes zoster and prevalence of postherpetic neuralgia: a retrospective survey in an elderly population. Eur J Pain 1999;3:335-42.
8. Bowsher D, Miles J, Haggett C, Eldridge P. Trigeminal neuralgia: a quantitative sensory perception threshold study in patients who had had no previous invasive procedures. J Neurosurg 1997;86:190-2.
9. Chan AW, Campbell JA, Bowsher D. Weighted pinprick sensory thresholds: a simple test of sensory function in diabetic peripheral neuropathy. J Neurol Neurosurg Psychiatry 1992;55:56-9.
10. Choo PW, Galil K, Donahue DVM, Walker AM, Spiegelman D, Platt R. Risk factors for postherpetic neuralgia. Arch Int Med 1997;157:1217-24.
11. Collins SL, Moore A, McQuay HJ, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia. J Pain Symptom Manage 2000;20:449-58.
12. Dworkin RH, Portenoy RK. Pain and its persistence in herpes zoster. Pain 1996;67:241-52.
13. Dworkin RH, Schmader KE. The epidemiology and natural history of herpes zoster and postherpetic neuralgia. In: Watson CPN, Gershon AA, editors. Herpes zoster and postherpetic neuralgia. Amsterdam: Elsevier; 2001. p. 39-64.
14. Fruhstorfer H, Lindblom U, Schmidt WG. Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 1976;39:1071-5.
15. Haanpää M, Laipalla P, Nurmikko T. Allodynia and pinprick hypoaesthesia in acute herpes zoster, and the development of postherpetic neuralgia. J Pain Symptom Manage 2000;20: 50-8.
16. Higa K, Mori M, Hirata K, Hori K, Manabe H, Dan K. Severity of skin lesions of herpes zoster at the worst phase rather than age and involved region most influences the duration of acute herpetic pain. Pain 1997;69:245-53.
17. Johnson RW. Herpes zoster-predicting and minimizing the impact of post-herpetic neuralgia. J Antimicrob Chemother 2001;47(Suppl. A):1-8.
18. Kugelberg E, Lindblom U. The mechanism of the pain in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1959;22:36-43.
19. Max MB, Culnane M, Schafer SC, Gracely RH, Walther DJ, Smoller B, Dubner R. Amitriptyline relieves diabetic neuropathy pain with normal or depressed mood. Neurology 1987;37:589-96.
20. Max MB, Kishore-Kumar R, Schafer SC, Meister B, Gracely RH, Smoller B, Dubner R. Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. Pain 1991;45:3-9.
21. Max MB, Lynch SA, Muir J, Shoaf FE, Smoller B, Dubner R. Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. N Engl J Med 1992;326:1287-8.
22. Max MB, Schafer SC, Culnane M, Dubner R, Gracely RH. Assocation of pain relief with drug side-effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo. Clin Pharmacol Ther 1988;43:363-71.
23. Melzack R. The McGill pain questionnaire: major properties and scoring methods. Pain 1975;1:277-99.
24. Meister W, Neiss A, Gross G, Doerr HW, Hobel W, Malin JP, von Essen J, Reimann BY, Witke C, Wutzler P. A prognostic score for postherpetic neuralgia in ambulatory patients. Infection 1998;26:359-63.
25. Mondelli M, Romano C, Passero S, Porta PD, Rossi A. Effects of acyclovir on sensory axonal neuropathy, segmental motor paresis and postherpetic neuralgia in herpes zoster patients. Eur Neurol 1996;36:288-92.
26. Ormrod D, Goa K. Valaciclovir: A review of its use in the management of herpes zoster. Drugs 2000;59:1317-40.
27. Rice ASC, Maton S, The Postherpetic Neuralgia Study Group (UK). Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001;94:215-224.
28. Rowbotham MC, Petersen KL, Fields HL. Is postherpetic neuralgia more than one disorder?. Pain Forum 1998;7:231-7.
29. Scadding JW. Peripheral Neuropathies. In: Wall PD, Melzack R, editors. Textbook of pain. 4th ed. Edinburgh: Churchill Living-stone; 1999. p. 815-34.
30. Semmes J, Weinstein S, Ghent L, Teuber HL. In: Somatosensory changes after penetrating wounds in man. Cambridge, MA: Harvard UP; 1960.
31. Sindrup SH, Jensen TS. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain 1999;83:389-400.
32. Watson CP. Postherpetic neuralgia: the importance of preventing this intractable end-stage disorder. J Infect Dis 1998;178(Suppl 1): S91-4.
33. Whitley RJ, Shukla S, Crooks RJ. The identification of risk factors associated with persistent pain following herpes zoster. J Infect Dis 1998;178(Suppl 1):S71-5.